Literature DB >> 7096274

Electrocardiographic changes and serum concentrations in thioridazine-treated patients.

R Axelsson, G Aspenstrom.   

Abstract

Electrocardiograms and serum concentrations of thioridazine and its metabolites were studied in 43 patients with paranoid psychosis. Two types of T-wave changes were distinguished: Type I with rounded, leveled, or notched T-waves, and Types II with diphasic waves. Significant positive correlations were found between serum drug concentrations and the Type I changes, while the Type II changes showed no concentration dependence. The two types of T-wave changes also differed in respect of prevalence, time of onset, duration, and variation with sex. The ECG response to thioridazine provides useful information about the serum drug concentrations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096274

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

Review 1.  Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors:  Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 2.  Assessing QT interval prolongation and its associated risks with antipsychotics.

Authors:  Jimmi Nielsen; Claus Graff; Jørgen K Kanters; Egon Toft; David Taylor; Jonathan M Meyer
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

3.  Near fatal case of self-poisoning with thioridazine.

Authors:  D Annane; F Girard; J E Fabre; J C Raphael; P Gajdos
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

Review 4.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.